Financial Partners Group (Kansas)’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-471
| Closed | -$234K | – | 212 |
|
|
2025
Q1 | $234K | Buy |
471
+60
| +15% | +$29.8K | 0.04% | 168 |
|
|
2024
Q4 | $214K | Sell |
411
-24
| -6% | -$12.5K | 0.03% | 174 |
|
|
2024
Q3 | $269K | Hold |
435
| – | – | 0.04% | 159 |
|
|
2024
Q2 | $240K | Hold |
435
| – | – | 0.04% | 158 |
|
|
2024
Q1 | $253K | Sell |
435
-42
| -9% | -$24.4K | 0.04% | 155 |
|
|
2023
Q4 | $253K | Buy |
477
+18
| +4% | +$9.56K | 0.05% | 140 |
|
|
2023
Q3 | $204K | Buy |
459
+63
| +16% | +$28K | 0.04% | 154 |
|
|
2023
Q2 | $217K | Hold |
396
| – | – | 0.04% | 145 |
|
|
2023
Q1 | $228K | Sell |
396
-23
| -5% | -$13.2K | 0.05% | 148 |
|
|
2022
Q4 | $241K | Buy |
+419
| New | +$241K | 0.05% | 146 |
|
|
2022
Q3 | – | Sell |
-381
| Closed | -$207K | – | 155 |
|
|
2022
Q2 | $207K | Buy |
381
+12
| +3% | +$6.52K | 0.05% | 142 |
|
|
2022
Q1 | $218K | Buy |
369
+17
| +5% | +$10K | 0.05% | 152 |
|
|
2021
Q4 | $205K | Hold |
352
| – | – | 0.04% | 157 |
|
|
2021
Q3 | $201K | Buy |
+352
| New | +$201K | 0.05% | 154 |
|